Home Compliance Pfizer’s Anti-Bribery Policy, a Decade After DOJ/SEC Settlement ComplianceNews Pfizer’s Anti-Bribery Policy, a Decade After DOJ/SEC Settlement January 14, 2022 32 Share FacebookLinkedinTwitter You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance CISA Unveils Final Self-Attestation Form for Software Producers Bidding on Federal Contracts Compliance The Maryland Online Data Privacy Act Set to Reshape the State Privacy Legislation Landscape with Stringent Requirements Compliance Selfish Foreign Policy Reasons, Not Altruism, Is Why Congress Enacted The FCPA